_____________________________________________ Commission file number: 001-34180 FLUIDIGM CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Indicate by che ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Address of principal executive offices Zip Code Registrant's telephone number, including area code: (650) 266-6000 _____________________________________________ or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...

Investor Presentation Q4 2020 February 10, 2021 Legal Information Forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding revenue growth and opportunities, development and expansion of Fluidigm's diagnostic business, new product releases, additional collaborations and partnerships, benefits and increasing adoption and utilization of Fluidigm mass cytometry produc ...

Fluidigm Corporation (FLDM) Q4 2020 Earnings Conference Call February 10, 2021 5:00 PM ET Company Participants Agnes Lee - Vice President, Investor Relations Chris Linthwaite - President and Chief Executive Officer Vikram Jog - Chief Financial Officer Conference Call Participants Sung Nam - BTIG Dan Brennan - UBS Steven Mah - Piper Sandler Operator Ladies and gentlemen, thank you for standing by, and welcome to Fluidigm Fourth Quarter 2020 Financial Results. [Operator instructions] please be advised that ...

Fluidigm Corporation (FLDM) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Agnes Lee - Vice President, Investor Relations Chris Linthwaite - President & Chief Executive Officer Vikram Jog - Chief Financial Officer Conference Call Participants Dan Brennan - UBS Steven Mah - Piper Sandler Operator Thank you for standing by, and welcome to the Fluidigm Third Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the spe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________________________________________ Commission file number: 001-34180 FLUIDIGM CORPORATION (Exact name ...

Fluidigm Corporation (FLDM) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Agnes Lee – Vice President-Investor Relations Chris Linthwaite – President and Chief Executive Officer Vikram Jog – Chief Financial Officer Conference Call Participants Sung Ji Nam – BTIG Nathan Treybeck – UBS Steven Mah – Piper Sandler Operator Good afternoon, ladies and gentlemen, and welcome to the Fluidigm Second Quarter 2020 Financial Results Conference Call. At this time, all participants are in ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________________________________________ Commission file number: 001-34180 FLUIDIGM CORPORATION (Exact name of r ...

Fluidigm Corporation Q2 2020 August 2020 FLUIDIGM® Forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding market opportunities and growth rates, access to infectious disease, immuno-oncology and diagnostics markets, expected uses for and advantages of company products, including a COVID-19 assay that is under FDA review, implementation and expected results of st ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________________________________________ Commission file number: 001-34180 FLUIDIGM CORPORATION (Exact name of ...